Author: Anna Smith

Lynparza gets FDA approval for ovarian cancer

Lynparza has been approved in the US for first-line maintenance therapy of BRCA-mutated advanced ovarian cancer.

28 cases of polio-like AFP seen in 2018

2018 has seen 28 cases of a polio-like illness called acute flaccid paralysis (AFP), more than double the typical yearly amount of less than ten, found in primarily children.

Alkermes and Biogen announce new MS drug application for FDA

Alkermes has submitted a New Drug Application (NDA) to the US Food and Drug Administration (FDA) for experimental multiple sclerosis (MS) drug diroximel fumarate.

Havas Lynx Group recruitment drive creates 60 new jobs

Havas Lynx Group has created as many as 60 new jobs with its largest ever recruitment drive.

75 projects to receive £1bn in NHS services upgrade

Health and Social Care secretary Matt Hancock has announced that £1 billion of funding will go to as many as 75 projects across England to upgrade facilities and treat more patients, including mental health and new integrated care services in the community.